0.5991
price down icon5.13%   -0.0324
after-market アフターアワーズ: .65 0.0509 +8.50%
loading
前日終値:
$0.6315
開ける:
$0.6211
24時間の取引高:
4.33M
Relative Volume:
1.33
時価総額:
$96.95M
収益:
$400.57M
当期純損益:
$9.21M
株価収益率:
14.98
EPS:
0.04
ネットキャッシュフロー:
$146.36M
1週間 パフォーマンス:
+5.79%
1か月 パフォーマンス:
-36.28%
6か月 パフォーマンス:
-82.98%
1年 パフォーマンス:
-90.11%
1日の値動き範囲:
Value
$0.59
$0.6423
1週間の範囲:
Value
$0.563
$0.67
52週間の値動き範囲:
Value
$0.5271
$7.105

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
名前
Ironwood Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
617-621-7722
Name
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
職員
253
Name
Twitter
@ironwoodpharma
Name
次回の収益日
2025-02-21
Name
最新のSEC提出書
Name
IRWD's Discussions on Twitter

IRWD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.5991 91.64M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-15 ダウングレード Jefferies Buy → Hold
2025-04-15 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 開始されました Leerink Partners Market Perform
2024-08-08 ダウングレード CapitalOne Overweight → Equal Weight
2024-01-17 開始されました Craig Hallum Buy
2023-12-14 開始されました Wells Fargo Overweight
2023-11-09 開始されました Jefferies Buy
2023-09-28 開始されました JMP Securities Mkt Outperform
2022-09-02 開始されました CapitalOne Overweight
2022-04-22 開始されました Piper Sandler Overweight
2020-09-30 ダウングレード Wells Fargo Overweight → Equal Weight
2020-06-17 開始されました Northland Capital Outperform
2019-07-10 再開されました Credit Suisse Neutral
2019-03-27 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-02-25 アップグレード H.C. Wainwright Sell → Neutral
2019-01-24 アップグレード JP Morgan Underweight → Neutral
2018-11-07 ダウングレード Credit Suisse Outperform → Neutral
2018-11-07 ダウングレード JP Morgan Neutral → Underweight
2018-07-23 開始されました H.C. Wainwright Sell
2018-05-09 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-01-05 ダウングレード BofA/Merrill Buy → Underperform
2017-12-06 ダウングレード Mizuho Buy → Neutral
2017-07-21 ダウングレード JP Morgan Overweight → Neutral
2017-05-03 開始されました Wells Fargo Outperform
2017-04-07 繰り返されました Mizuho Buy
2017-02-22 繰り返されました Barclays Equal Weight
2016-11-04 繰り返されました Mizuho Buy
2016-10-24 繰り返されました Wedbush Neutral
2016-10-10 繰り返されました Mizuho Buy
2016-09-27 繰り返されました WallachBeth Hold
すべてを表示

Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース

pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025
pulisher
May 09, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $4.78 - Defense World

May 09, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire

May 07, 2025
pulisher
May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025
pulisher
Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025
pulisher
Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Jefferies Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Wells Fargo Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood's Strategy Shake-Up Raises Eyebrows As Shares Tumble - Finimize

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges (IRWD:NASDAQ) - Seeking Alpha

Apr 15, 2025

Ironwood Pharmaceuticals Inc (IRWD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_specialty_generic RGC
$877.00
price up icon 18.36%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$318.85
price down icon 0.47%
$16.78
price down icon 4.28%
大文字化:     |  ボリューム (24 時間):